Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short...
Hear from Xstrahl's CEO, Adrian Treverton, on the future of skin cancer treatment. https://vimeo.com/718012693
Kilovoltage X-ray equipment maintains an integral role in the modern radiation therapy department for the treatment of non-melanoma skin cancer as well as other benign conditions and palliative applications. The use of low energy, therapeutic X-rays is often a...
Non-melanoma skin cancer is the most common cancer in the world today, with approximately 1.5 million cases in 2016—and that number is growing rapidly. While this type of cancer has a low morbidity rate, surgical treatment often leaves patients with dysfunctions,...
Dr Hubert Urbańczyk przedstawi grupy pacjentów, którzy mogą być dobrymi kandydatami do RT ortowoltowej, która może mieć równe lub lepsze efekty w porównaniu do RT megawoltowej: • Aktualne kliniczne zastosowanie RT ortowoltowej w chorobach nowotworowych (m.in....
Dr Dominika Oborska-Kumaszyńska, zakres prezentacji (prezentacja przygotowana przez zespól fizyków medycznych z Cancer Center London): • LET (zalety zasilania LET środki energii kV w porównaniu z promieniowaniem fotonowym wysokiej energii) • Testy akceptacyjne, testy...
In this webcast, Dr. Richard Shaffer presents on a range of clinical conditions that can be treated with superficial-orthovoltage radiotherapy machines. The presentation primarily focuses on the treatment of non-melanoma skin cancer, including several illustrative...
In this webcast, the SmART Scientific Solutions team shares about and demonstrates SmART-XPS, the new treatment planning system for SARRP. https://vimeo.com/718024746
Explore how radiotherapy can be used to treat keloid scarring in this presentation by Dr. Richard Shaffer. https://vimeo.com/718026742
Contact Us